Early research (Phase 1)Active Not RecruitingNCT03319940
What this trial is testing
Study Evaluating Safety, Tolerability and Pharmacokinetics (PK) of Tarlatamab in Adults With Small Cell Lung Cancer (SCLC)
Who this might be right for
Small Cell Lung Carcinoma
Amgen 269